BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 24025411)

  • 1. Advances in the understanding of the Fanconi anemia tumor suppressor pathway.
    Pickering A; Zhang J; Panneerselvam J; Fei P
    Cancer Biol Ther; 2013 Dec; 14(12):1089-91. PubMed ID: 24025411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Convergence of Rad6/Rad18 and Fanconi anemia tumor suppressor pathways upon DNA damage.
    Park HK; Wang H; Zhang J; Datta S; Fei P
    PLoS One; 2010 Oct; 5(10):e13313. PubMed ID: 20967207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rad18-mediated translesion synthesis of bulky DNA adducts is coupled to activation of the Fanconi anemia DNA repair pathway.
    Song IY; Palle K; Gurkar A; Tateishi S; Kupfer GM; Vaziri C
    J Biol Chem; 2010 Oct; 285(41):31525-36. PubMed ID: 20675655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FANCD2 monoubiquitination provides a link between the HHR6 and FA-BRCA pathways.
    Zhang J; Zhao D; Wang H; Lin CJ; Fei P
    Cell Cycle; 2008 Feb; 7(3):407-13. PubMed ID: 18277096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coordination of the recruitment of the FANCD2 and PALB2 Fanconi anemia proteins by an ubiquitin signaling network.
    Bick G; Zhang F; Meetei AR; Andreassen PR
    Chromosoma; 2017 Jun; 126(3):417-430. PubMed ID: 27277787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FANCD2 and DNA Damage.
    Nepal M; Che R; Ma C; Zhang J; Fei P
    Int J Mol Sci; 2017 Aug; 18(8):. PubMed ID: 28825622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rad18 confers hematopoietic progenitor cell DNA damage tolerance independently of the Fanconi Anemia pathway in vivo.
    Yang Y; Poe JC; Yang L; Fedoriw A; Desai S; Magnuson T; Li Z; Fedoriw Y; Araki K; Gao Y; Tateishi S; Sarantopoulos S; Vaziri C
    Nucleic Acids Res; 2016 May; 44(9):4174-88. PubMed ID: 26883629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rad18 E3 ubiquitin ligase activity mediates Fanconi anemia pathway activation and cell survival following DNA Topoisomerase 1 inhibition.
    Palle K; Vaziri C
    Cell Cycle; 2011 May; 10(10):1625-38. PubMed ID: 21478670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel role for Fanconi anemia (FA) pathway effector protein FANCD2 in cell cycle progression of untransformed primary human cells.
    Song IY; Barkley LR; Day TA; Weiss RS; Vaziri C
    Cell Cycle; 2010 Jun; 9(12):2375-88. PubMed ID: 20519958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Fanconi anemia ID2 complex: dueling saxes at the crossroads.
    Boisvert RA; Howlett NG
    Cell Cycle; 2014; 13(19):2999-3015. PubMed ID: 25486561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro FANCD2 monoubiquitination by HHR6 and hRad18.
    Pickering A; Panneerselvam J; Zhang J; Zheng J; Zhang Y; Fei P
    Cell Cycle; 2013 Nov; 12(21):3448-9. PubMed ID: 24036990
    [No Abstract]   [Full Text] [Related]  

  • 12. Deficiencies in the Fanconi anemia DNA damage response pathway increase sensitivity to HPV-associated head and neck cancer.
    Park JW; Pitot HC; Strati K; Spardy N; Duensing S; Grompe M; Lambert PF
    Cancer Res; 2010 Dec; 70(23):9959-68. PubMed ID: 20935219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Focal Point of Fanconi Anemia Signaling.
    Zhan S; Siu J; Wang Z; Yu H; Bezabeh T; Deng Y; Du W; Fei P
    Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Fanconi anemia pathway is downregulated upon macrophage differentiation through two distinct mechanisms.
    Lu WT; Lemonidis K; Drayton RM; Nouspikel T
    Cell Cycle; 2011 Oct; 10(19):3300-10. PubMed ID: 21926477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism of Ubiquitination and Deubiquitination in the Fanconi Anemia Pathway.
    van Twest S; Murphy VJ; Hodson C; Tan W; Swuec P; O'Rourke JJ; Heierhorst J; Crismani W; Deans AJ
    Mol Cell; 2017 Jan; 65(2):247-259. PubMed ID: 27986371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel role for non-ubiquitinated FANCD2 in response to hydroxyurea-induced DNA damage.
    Chen X; Bosques L; Sung P; Kupfer GM
    Oncogene; 2016 Jan; 35(1):22-34. PubMed ID: 25893307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Promyelocytic Leukemia Proteins Regulate Fanconi Anemia Gene Expression.
    Munkhjargal A; Kim MJ; Kim DY; Jeon YJ; Kee YH; Kim LK; Kim YH
    Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of the activation of the Fanconi anemia pathway by the p21 cyclin-dependent kinase inhibitor.
    Rego MA; Harney JA; Mauro M; Shen M; Howlett NG
    Oncogene; 2012 Jan; 31(3):366-75. PubMed ID: 21685936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Physical and functional crosstalk between Fanconi anemia core components and the GINS replication complex.
    Tumini E; Plevani P; Muzi-Falconi M; Marini F
    DNA Repair (Amst); 2011 Feb; 10(2):149-58. PubMed ID: 21109493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Fanconi anemia pathway: insights from somatic cell genetics using DT40 cell line.
    Takata M; Ishiai M; Kitao H
    Mutat Res; 2009 Jul; 668(1-2):92-102. PubMed ID: 19622405
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.